Articles on anti-retrovirals

Displaying all articles

For the next five years South Africa will be leading one of the latest large-scale trials for a vaccine for HIV.

The WHO has recommended pre-exposure prophylaxis, or PrEP, as an additional HIV prevention choice for people with a high risk of being infected. Truvada has been licensed in South Africa.
Epa/Maurizio GambariniDecember 21, 2015